Skip to search formSkip to main contentSkip to account menu

mivazerol

Known as: alpha-imidazol-4-yl-2,3-cresotamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Background: We have previously reported that mivazerol, a α2‐agonist, possibly provides neuroprotection against transient… 
1999
1999
A specific α2 agonist, mivazerol, known to be effective in reducing myocardial ischaemia when given intravenously immediately… 
1998
1998
Background: Mivazerol (MIV) is anα2‐adrenoceptor agonist designed to prevent adverse cardiac outcome in perioperative patients… 
1998
1998
The rostral ventrolateral medulla (RVLM) controls the vascular system and may contribute to postoperative hypertension.It… 
1997
1997
BACKGROUND Mivazerol hydrochloride is a new alpha 2-adrenoceptor agonist. In vitro and animal studies have demonstrated both… 
1997
1997
1996
1996
Summary— Mivazerol is a new compound that could potentially reduce perioperative cardiovascular morbidity and mortality in… 
1993
1993
SummaryIn a double-blind, placebo-controlled, randomized trial of treadmill exercise tolerance in six patients with chronic…